Citadel Advisors’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $9.99M | Sell |
|
|||||
|
2025
Q2 | $17.5M | Buy |
|
|||||
|
2025
Q1 | $15.9M | Buy |
|
|||||
|
2024
Q4 | $16.9M | Buy |
|
|||||
|
2024
Q3 | $22.6M | Sell |
|
|||||
|
2024
Q2 | $28.3M | Sell |
|
|||||
|
2024
Q1 | $28M | Buy |
|
|||||
|
2023
Q4 | $1.46M | Buy |
|
|||||
|
2023
Q3 | $1.28M | Buy |
|
|||||
|
2023
Q2 | $1.66M | Sell |
|
|||||
|
2023
Q1 | $31.7M | Buy |
|
|||||
|
2022
Q4 | $963K | Sell |
|
|||||
|
2022
Q3 | $1.95M | Sell |
|
|||||
|
2022
Q2 | $9.01M | Sell |
|
|||||
|
2022
Q1 | $24.2M | Buy |
|
|||||
|
2021
Q4 | $21.7M | Buy |
|
|||||
|
2021
Q3 | $3.18M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $13.7M | Buy |
|
|||||
|
2020
Q4 | $428K | Sell |
|
|||||
|
2020
Q3 | $7.82M | Buy |
|
|||||
|
2020
Q2 | $2.67M | Buy |
|
|||||
|
2020
Q1 | $1.27M | Buy |
|
|||||
|
2019
Q4 | $933K | Sell |
|
|||||
|
2019
Q3 | $1.35M | Sell |
|
|||||
|
2019
Q2 | $4.04M | Buy |
|
|||||
|
2019
Q1 | $645K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $753K | Buy |
|